Background: Health care-associated antibiotic-resistant (AR) infections increase patient morbidity and mortality and might be impossible to successfully treat with any antibiotic. CDC assessed health care-associated infections (HAI), including Clostridium difficile infections (CDI), and the role of six AR bacteria of highest concern nationwide in several types of health care facilities.
Introduction
Antibiotic-resistant (AR) bacteria are a worldwide public health threat. A 2013 CDC report outlined the top 18 urgent, serious, and concerning AR threats in the United States (1) . Among the 15 urgent and serious threats, seven are bacteria predominately acquired during health care. Clostridium difficile is included among these; although C. difficile is not drugresistant, the infections it causes and its spread are exacerbated by inappropriate antibiotic use and inadequate infection control, similar to the six other AR bacteria. Preventing health care-associated infections (HAIs) provides immediate benefit in reducing the impact of antibiotic resistance on human health. When combined with antibiotic stewardship and steps to prevent transmission as outlined in the National Action Plan to Combat Antibiotic Resistant Bacteria (2), preventing HAIs is critical to reducing the public health threat of AR bacteria.
More than half of hospitalized patients are receiving antibiotics on any given day (3) , and about one in 25 have one or more HAIs (4) . During 2011 an estimated 722,000 HAIs occurred in U.S acute care hospitals, and approximately 75,000 patients with HAIs died during hospitalization (4) . More than half of these HAIs include C. difficile infections (CDIs), urinary tract infections, bloodstream infections, or surgical site infections (SSIs). The HAI National Action Plan (5) calls for CDC to monitor progress toward established goals through the National Healthcare Safety Network (NHSN). This report describes progress toward reducing HAIs in the United States and describes the frequency of six AR bacteria of urgent or serious public health concern among reported HAIs in 2014.
Methods
HAI data on central line-associated bloodstream infections (CLABSIs), catheter-associated urinary tract infections (CAUTIs), surgical site infections (SSIs), and laboratoryidentified CDI events for 2014 were reported to NHSN from hospitals in all 50 states, the District of Columbia, and Puerto Rico, using standard NHSN definitions (6) (7) (8) . Data are presented separately for acute care hospitals (including critical access hospitals), long-term acute care hospitals, and inpatient rehabilitation facilities, because reporting timelines and type of HAIs reported varied among the different settings.
Standardized infection ratios (SIRs), a statistic used to track HAIs over time, were used to compare the observed number of infections reported during 2014 with the predicted number of infections, based on national aggregate data reported during a historical baseline time period. SIRs for different infections were adjusted for key risk factors (9) (10) (11) . Baseline time periods among short-term acute care hospitals were 2006-2008 for  CLABSIs and SSIs, 2009 for CAUTIs, and 2010-2011 for CDIs. Among long-term acute care hospitals and inpatient rehabilitation facilities the baseline time period was 2013 for both CLABSIs and CAUTIs. The SSI data include 10 procedures that approximate procedures included in the Centers for Medicare and Medicaid Services Surgical Care Improvement Project and were performed during 2014 (10) .
Pathogen and susceptibility data are provided by the facility's designated clinical microbiology laboratory. No more than three pathogens per HAI could be reported. Susceptibility results for each pathogen were reported as "susceptible," "intermediate," "resistant," or "not tested" (12) . The six AR phenotypes included the urgent threat of carbapenemresistant Enterobacteriaceae, along with the serious threats of methicillin-resistant Staphylococcus aureus, vancomycinresistant enterococci, extended-spectrum beta-lactamase phenotype Enterobacteriaceae, multidrug-resistant (MDR) P. aeruginosa, and MDR Acinetobacter species. The criteria used to define each phenotype approximated interim standard definitions for defining multidrug resistance as used in the CDC AR Threat Report (1), along with updated criteria for carbapenem-resistant Enterobacteriaceae (13) .
A pooled mean percentage of resistant pathogens, based on the sum of pathogens that tested resistant, divided by the sum of pathogens tested, was calculated for each threat pathogen by HAI type and facility type. In addition, the likelihood that an HAI was associated with any of the six antibiotic-resistant threat pathogens was calculated as the sum of HAIs with any resistant phenotype divided by the sum of HAIs reported (regardless of whether another pathogen or, in the case of SSI, no pathogen was reported).
Results
In 2014, approximately 4,000 acute care hospitals (3, (Figure) . The percentage change from 2013 to 2014 was −8% for CLABSI, −5% CAUTI, +4% for CDI, and +2% for SSI.
Among long-term acute care hospitals, 2,928 CLABSIs and 4,467 CAUTIs were reported; after risk adjustment, the SIRs were 0.909 (0.876-0.942) for CLABSI and 0.893 (0.867-0.920) for CAUTI, corresponding to 9% and 11% decreases, respectively, compared with baseline. Within inpatient rehabilitation facilities, 1,449 CAUTIs were reported, for an SIR of 0.856 (0.813-0.901) or a 14% reduction compared with baseline.
Combining HAIs across all settings, 47.9% of S. aureus infections were resistant to methicillin, 29.5% of enterococci were resistant to vancomycin, 17.8% of Enterobacteriaceae were extended-spectrum beta-lactamase phenotype, 3.6% of Enterobacteriaceae were carbapenem-resistant, 15.9% of P. aeruginosa, and 52.6% of Acinetobacter species were MDR. Notably, the percentage resistance varied by facility type and was consistently higher in long-term acute care hospitals (Table) .
During 2014, the likelihood of any of the six AR threat bacteria varied by HAI type and facility type. Overall, among short-term acute care hospitals, 14% of all HAIs were caused by one of the six AR threat bacteria, including 18% of CLABSIs (3,348 of 18,373), 15% of SSIs (2,583 of 17,512), 10% of CAUTIs (3,601 of 34,621). Among long-term acute care hospitals, 28% of CLABSIs (808 of 2,873) and 29% of CAUTIs 
Conclusions and Comment
In the United States, approximately 2 million persons become ill every year with AR infections, and approximately 23,000 die. This report is the first to combine national data on AR bacteria threats with progress on HAI prevention. In 2014, the incidence of CLABSI in acute care hospitals reached the 2013 goal established by the HAI Action Plan (5), decreasing 50% during 2008-2014. This is important given the high morbidity, mortality, and excess costs associated with CLABSIs (14, 15) , which are partially related to the frequency with which methicillin-resistant Staphylococcus aureus, vancomycinresistant enterococci, and extended-spectrum beta-lactamase phenotype Enterobacteriaceae cause these infections (Table) . In addition, CAUTIs in acute care hospitals decreased overall by 5% during 2013-2014 and, although not quantified in (17) . The CDI SIR in acute care hospitals decreased only 8% overall during 2011-2014, and more concerning, increased 4% during 2013-2014. More work is needed to ensure that patients are safe from C. difficile and AR bacteria.
Controlling AR threats is linked to preventing the occurrence of HAIs, reducing selective pressure by improving overall antibiotic stewardship, and preventing the spread of AR bacteria within and between facilities. Preventing catheter-and procedure-related infections can be accomplished by always following recommended indications and guidelines for insertion, maintenance, and removal of vascular and bladder catheters. CDC and its partners are implementing new HHS-proposed HAI targets for December 2020, using 2015 NHSN data as its new baseline. A key strategy for reaching these goals is the Targeted Assessment for Prevention strategy to identify gaps in infection control in facilities with a disproportionate number of HAIs (18) . In addition to reducing the need for antibiotics used in treatment, preventing HAIs prevents complications of infection, including sepsis, a major cause of death In conjunction with HAI prevention is implementation of hospital antibiotic stewardship programs (19) . This is accomplished by always obtaining cultures when starting necessary antibiotics and, especially in septic patients, doing so promptly, using culture results to reassess the continued need for antibiotics, discontinuing antibiotics that are no longer needed or to which AR has developed, and using the appropriate drug at the proper dose and administration frequency. Antibiotic exposure is well recognized as the most important modifiable risk factor for CDI, and antibiotic stewardship is potentially the most effective CDI prevention strategy (17, 19) . The emergence and spread of the hypervirulent, fluoroquinoloneresistant, ribotype 027 strain of C. difficile in North America and Europe was facilitated by increased use of fluoroquinolones (20) . Reducing unnecessary use of this antibiotic class has been instrumental in facilities where control of this strain has been achieved (21, 22) . What is less widely recognized is the role that disruption of the human microbiome has on increasing patients' risk for acquiring AR strains of other HAI pathogens (23) and, once colonized, developing infection (24) . Genes that confer resistance can be carried on the same plasmid or chromosome as genes that increase bacterial virulence, leading to the emergence of highly adapted AR HAI pathogens (25) . CDC summarizes core elements of successful stewardship programs, which can help assure the prompt initiation of necessary antibiotics and reduce unnecessary antibiotic use, thereby reducing the risk of CDI and AR infections, improving individual patient outcomes, and saving health care dollars (19) .
In conjunction with HAI prevention and antibiotic stewardship, the third necessary strategy is the prevention of cross transmission. To achieve this, physicians, nurses, and health care leaders need to improve hand hygiene, room cleaning, and use of personal protective equipment, and be aware of HAI outbreaks caused by AR bacteria in their hospital or region. In the case of C. difficile, which is unique among the AR threat bacteria in forming spores, special environmental measures might also be needed to prevent transmission (17) . Because AR strains might be more virulent than other strains and thereby more likely to colonize and infect patients already receiving antibiotics, interrupting transmission of these strains reduces both the number of HAIs and the likelihood that an HAI is caused by an AR threat. To assist clinicians, health care leaders, and state and local public health authorities to learn when well-adapted resistant strains are emerging and spreading in a region, CDC is working with partners to build networks to better detect and respond to AR threats and to make antibiotic resistance data from health care facilities more readily accessible through a new HAI Antibiotic Resistance Patient Safety Atlas. † Over one of every four HAIs reported from long-term acute care hospitals were caused by AR bacteria. Moreover, limited data suggest CDI incidence in long-term acute care hospitals might be several fold higher than in short-term acute care hospitals (26, 27) . One contributing factor is patient transfer from intensive care units of acute care hospitals where their microbiomes have been disrupted by exposure to antibiotics and where they have been colonized with AR threat bacteria (28) . Long-term acute care hospitals are facilities that can transmit or amplify antibiotic resistance within a community † http://www.cdc.gov/hai/surveillance/ar-patient-safety-atlas.html.
Key Points
• Antibiotic-resistant (AR) bacteria can make infections impossible to treat, especially given the extensive resistance frequently encountered in health care facilities. of interconnected health care facilities (29) . It is critical for interconnected health care facilities to work together for early detection and response to emerging AR threats; coordinated prevention initiatives have the biggest impact on a community or region overall (30) . Through sharing of information, practical expertise, and regional leadership, coordinated activity can have a larger impact on preventing transmission and infections with antibiotic-resistant bacteria than hospitals working alone. The findings in this report are subject to at least two limitations. First, infections included in SIR calculations were a subset of all the infections evaluated for AR. The latter included infection events reported from any type of SSI, and infections occurring in locations regardless of eligibility to calculate a SIR. Second, the reported resistance relied on the manual reporting of the facility staff, based on reports provided by the clinical laboratory, and might contain inaccurate test results, data entry errors, and some incomplete information. Despite these limitations, these data provide important information on the status of HAI infection prevention in the United States in 2014 and the persistent challenge of preventing the spread of AR bacteria in a variety of inpatient health care settings. Preventing HAIs and the spread of antibiotic resistance is possible if physicians, nurses, and health care leaders consistently and comprehensively follow all recommendations to prevent HAIs, including prevention of catheter-and procedure-related infections, antimicrobial stewardship, and implementation of measures to prevent spread.
